Content about Monoclonal antibodies

June 14, 2010
Genzyme's Campath gets fast-track designation from FDA

The Food and Drug Administration has agreed to speed up the review of a Genzyme...

June 14, 2010
Immunomedics starts milatuzumab trial

Immunomedics has started a trial of an investigational drug for treating cancer of the plasma...

June 9, 2010
Human Genome Sciences, GSK submit approval application for lupus drug

Human Genome Sciences has submitted an approval application for a treatment for lupus, development partner...

June 6, 2010
Bristol-Myers Squibb: Skin cancer drug increased patient survival in clinical trial

An investigational drug for skin cancer that had spread to other parts of the body...

May 24, 2010
Report: Teva recruits patients for Rituxan biosimilar trial

Generic drug maker Teva Pharmaceutical Industries isn’t holding back in its effort to push into...

May 23, 2010
Biogen Idec, Abbott enroll patients in late-stage trial for MS drug

Swiss biotech company Biogen Idec and U.S. drug maker Abbott have begun enrolling patients in...

May 20, 2010
Boehringer Ingelheim's cancer drug may be 'next generation' treatment

Data from a late-stage clinical trial of an investigational drug by Boehringer Ingelheim could show...

May 18, 2010
Genentech receives FDA approval for Actemra

The Food and Drug Administration has approved a new biotech drug made by Roche U.S....

May 16, 2010
Lilly to present more than 50 studies at oncology conference

The cancer drug arm of Eli Lilly plans to show data from more than 50...

May 2, 2010
Study: Combination therapy may improve diabetic macular edema

A combination of a biotech drug and laser treatment may improve vision in patients with...

March 22, 2010
FDA committee won't recommend approval for non-Hodgkin’s lymphoma treatment

A Food and Drug Administration advisory committee declined to recommend approval for a cancer drug...

March 17, 2010
Roche calls its R&D status 'uniquely positioned'

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 11, 2010
Late-stage clinical trial of Avastin fails to meet expectations, Genentech says

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 11, 2010
Pfizer says clinical trials for Sutent did not meet expectations; halts additional cancer treatment study

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

March 9, 2010
Abbott to boost business with Facet acquisition

Abbott will acquire Facet Biotech for $450 million, the drug maker announced Wednesday....

March 7, 2010
Roche, Biogen Idec halt ocrelizumab trials

Roche and Biogen Idec are suspending trials of a drug for treating autoimmune disorders amid...

February 24, 2010
Genentech reports positive clinical results in Avastin trial

A late-stage clinical trial of a drug by Genentech indicates that combining it with chemotherapy...

February 21, 2010
Decision Resources projects Crohn's disease market surge

The high prices of drugs made by Johnson & Johnson and Abbott will drive the...

February 18, 2010
Rituxan gets nod of approval from FDA

The Food and Drug Administration has approved a drug made by Roche subsidiary Genentech and...

February 8, 2010
Amgen's prostate cancer drug more effective than competitor, study concludes

An investigational drug made by Amgen for treating prostate cancer that had spread to the...

January 11, 2010
Biogen Idec seeks approval in Canada, European Union for MS drug

Biogen Idec hopes to win approval for a multiple sclerosis drug in Canada and the...

January 10, 2010
FDA approves Genentech's new rheumatoid arthritis treatment

The Food and Drug Administration has approved a Genentech drug for treating rheumatoid arthritis, the...

January 6, 2010
Pfizer to develop cancer drug with Debiopharm

Two drug makers have entered an agreement to develop a drug designed to treat melanoma....

January 3, 2010
Decision Resources projects same U.S., Europe patient share of ulcerative colitis biologic

A new report by Decision Resources revealed that a biological therapy with a mechanism of...

August 20, 2009
Teva launches ‘Patient First’ project

Most consumers may not know a lot about biosimilar equivalence, immunogenicity or what “monoclonal antibody”...

© 2013 Drug Store News. All Rights Reserved.